Showing results (91-100 of 101) with videos related to
Sort By:
Pageof 11
Bioorganic & Medicinal Chemistry|January 9, 2014
Design, synthesis and biological evaluation of 3,5-disubstituted 2-amino thiophene derivatives as a novel class of antitumor agentsRomeo Romagnoli, Pier Giovanni Baraldi, Carlota Lopez-Cara, et al.The Journal of Experimental Medicine|November 14, 2012
A novel role of sphingosine 1-phosphate receptor S1pr1 in mouse thrombopoiesisLin Zhang, Martin Orban, Michael Lorenz, et al.Oncotarget|July 25, 2018
TRPC4/TRPC5 channels mediate adverse reaction to the cancer cell cytotoxic agent (-)-Englerin ASin Ying Cheung, Matthias Henrot, Mohammad Al-Saad, et al.Chemistry & Biology|July 30, 2013
PIKfyve, a class III PI kinase, is the target of the small molecular IL-12/IL-23 inhibitor apilimod and a player in Toll-like receptor signalingXinming Cai, Yongyao Xu, Atwood K Cheung, et al.The Journal of Biological Chemistry|March 23, 2017
Picomolar, selective, and subtype-specific small-molecule inhibition of TRPC1/4/5 channelsHussein N Rubaiy, Melanie J Ludlow, Matthias Henrot, et al.Nature|December 17, 2020
Small-molecule inhibitors of human mitochondrial DNA transcriptionNina A Bonekamp, Bradley Peter, Hauke S Hillen, et al.Chemmedchem|September 30, 2017
Identification of Atuveciclib (BAY 1143572), the First Highly Selective, Clinical PTEFb/CDK9 Inhibitor for the Treatment of CancerUlrich Lücking, Arne Scholz, Philip Lienau, et al.Cell Chemical Biology|February 4, 2018
Dynarrestin, a Novel Inhibitor of Cytoplasmic DyneinSusanne Höing, Ting-Yu Yeh, Matthias Baumann, et al.Journal of Medicinal Chemistry|April 29, 2022
Insight into Targeting Exon20 Insertion Mutations of the Epidermal Growth Factor Receptor with Wild Type-Sparing InhibitorsJonas Lategahn, Hannah L Tumbrink, Carsten Schultz-Fademrecht, et al.Stem Cell Reports|February 19, 2019
Dual Inhibition of GSK3β and CDK5 Protects the Cytoskeleton of Neurons from Neuroinflammatory-Mediated Degeneration In Vitro and In VivoLydia Reinhardt, Susanne Kordes, Peter Reinhardt, et al.Pageof 11